Glargine and degludec: Solution behaviour of higher dose synthetic insulins

Single, double and triple doses of the synthetic insulins glargine and degludec currently used in patient therapy are characterised using macromolecular hydrodynamic techniques (dynamic light scattering and analytical ultracentrifugation) in an attempt to provide the basis for improved personalised...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Gary G., Alzahrani, Qushmua, Jiwani, Shahwar I., Meal, Andrew, Morgan, Paul S., Coffey, Frank, Kok, Samil, Rowe, Arthur J., Harding, Stephen E., Chayen, Naomi, Gillis, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544765/
https://www.ncbi.nlm.nih.gov/pubmed/28779138
http://dx.doi.org/10.1038/s41598-017-06642-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544765/
https://www.ncbi.nlm.nih.gov/pubmed/28779138
http://dx.doi.org/10.1038/s41598-017-06642-w

Ejemplares similares